Mizuho Upgrades Depomed On Increased Takeout Probability

By: via Benzinga
Depomed Inc (NASDAQ: DEPO) reported lower-than-expected 1Q16 revenues of $104.8 million and EPS of $0.12. Mizuho’s Irina R. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.